Experts are presenting innovative methods for repairing nerve harm and reporting about their studies on the therapeutic potential of stem cells in treating multiple sclerosis. Rhodos, 18 June 2007 – Neurological diseases are more and more widespread across the world, especially in Europe, and incur large costs, warned Professor Dr. Ioannis Milonas at the annual Congress of the European Neurological Culture on the Greek island of Rhodos. Relating to WHO data, neurological illnesses as well as mental and neurosurgical struggling account for a minimum of 35 % of medical care burden in European countries, noted Professor Milonas, head of the Department of Neurology at the University of Thessaloniki and chairman of the ENS Congress.‘CB1 antagonists still hold promise for fighting weight problems and diabetes-the problem is finding one that will not engage the receptors in regions of the mind that control mood and still maintains its enormous calorie-burning properties,’ explains Obici, senior author of the UC study. ‘We have shown that the effective ramifications of CB1 antagonists on brown adipose cells are mediated by the sympathetic nervous program. With further study, this may lead to a more effective and safer drug technique for glucose regulation and weight loss.’ Obici is currently conducting further research to look for the specific location of the CB1 receptor in the sympathetic anxious program that activates the calorie-burning, glucose-consuming properties of brownish adipose tissue.